tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:38I Stock Latest News

Cathie Wood’s ARK Investment buys 131.7K shares of Intellia Therapeutics today
The FlyCathie Wood’s ARK Investment buys 131.7K shares of Intellia Therapeutics today
9d ago
NTLA
Cathie Wood’s ARK Investment buys 169.7K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 169.7K shares of Intellia Therapeutics today
11d ago
NTLA
Cathie Wood’s ARK Investment buys 133K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 133K shares of Intellia Therapeutics today
15d ago
NTLA
Cathie Wood’s ARK Investment buys 350K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 350K shares of Intellia Therapeutics today
16d ago
NTLA
Cathie Wood’s ARK Investment buys 185.2K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 185.2K shares of Intellia Therapeutics today
17d ago
NTLA
Cathie Wood’s ARK Investment buys 191.7K shares of Intellia Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 191.7K shares of Intellia Therapeutics today
18d ago
NTLA
Cathie Wood’s ARK Investment buys 359K shares of Intellia Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 359K shares of Intellia Therapeutics today
19d ago
NTLA
Cathie Wood’s ARK Investment buys 150.6K shares of Intellia Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 150.6K shares of Intellia Therapeutics today
24d ago
NTLA
Cathie Wood’s ARK Investment buys 560.6K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 560.6K shares of Intellia Therapeutics today
26d ago
NTLA
Intellia Therapeutics’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Intellia Therapeutics’ Earnings Call Highlights Progress and Challenges
1M ago
NTLA
Intellia Therapeutics price target lowered to $45 from $50 at Wells Fargo
PremiumThe Fly
Intellia Therapeutics price target lowered to $45 from $50 at Wells Fargo
1M ago
NTLA
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
PremiumThe Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
1M ago
NTLA
Intellia Therapeutics Reports Q2 2025 Progress and Financials
PremiumCompany AnnouncementsIntellia Therapeutics Reports Q2 2025 Progress and Financials
1M ago
NTLA
Intellia Therapeutics: Strategic Advancements and Promising Clinical Trials Justify Buy Rating
Premium
Ratings
Intellia Therapeutics: Strategic Advancements and Promising Clinical Trials Justify Buy Rating
1M ago
NTLA
Intellia Therapeutics: Strategic Advancements and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Intellia Therapeutics: Strategic Advancements and Promising Clinical Developments Drive Buy Rating
1M ago
NTLA
Intellia Therapeutics price target lowered to $21 from $25 at RBC Capital
PremiumThe Fly
Intellia Therapeutics price target lowered to $21 from $25 at RBC Capital
1M ago
NTLA
Intellia Therapeutics Announces Executive Retirement
PremiumCompany Announcements
Intellia Therapeutics Announces Executive Retirement
1M ago
8K
NTLA
Intellia Therapeutics reports Q2 EPS (98c), consensus ($1.01)
PremiumThe Fly
Intellia Therapeutics reports Q2 EPS (98c), consensus ($1.01)
1M ago
NTLA
Intellia Therapeutics sees cash runway into 1H27
PremiumThe Fly
Intellia Therapeutics sees cash runway into 1H27
1M ago
NTLA
Intellia Therapeutics announces employee inducement grants
PremiumThe FlyIntellia Therapeutics announces employee inducement grants
1M ago
NTLA
Promising Phase 1 Results and High Interest in Phase 3 Trial Boost Buy Rating for Intellia Therapeutics
Premium
Ratings
Promising Phase 1 Results and High Interest in Phase 3 Trial Boost Buy Rating for Intellia Therapeutics
3M ago
NTLA
Intellia Therapeutics Announces Positive Phase 1 Trial Data
Premium
Company Announcements
Intellia Therapeutics Announces Positive Phase 1 Trial Data
3M ago
8K
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >